MTND1P3: A Potential Drug Target and Biomarker (G100288984)

Target Name: MTND1P3

NCBI ID: G100288984

MTND1P3

Other Name(s): MT-ND1 pseudogene 3

MTND1P3: A Potential Drug Target and Biomarker

Mitochondrial dysfunction (MCD) is a condition characterized by the impaired function of mitochondria, which are the energy-producing structures in cells. It is a leading cause of death in humans, affecting approximately 10 million individuals worldwide. MCD can be caused by a variety of factors, including genetic mutations, infections, and lifestyle factors.

One of the main challenges in the treatment of MCD is the limited understanding of its underlying mechanisms. While several potential drug targets have been identified, there is currently no approved therapy for MCD.

MTND1P3, a gene encoding a protein known as mitochondrial protein 1 (MT1), is a potential drug target for MCD. MT1 is a key component of the mitochondrial outer membrane, which is responsible for maintaining the structure and function of the mitochondria.

MTND1P3 functions as a chaperone, helping to transport proteins across the mitochondrial membrane. It also plays a role in regulating the stability of the mitochondrial outer membrane, which is crucial for maintaining the integrity of the mitochondria.

Several studies have suggested that MT1 may be a potential drug target for MCD. For example, animal models of MCD have been treated with drugs that specifically target MT1, and some have shown improvement in symptoms.

In addition to its potential therapeutic applications, MTND1P3 is also a biomarker for MCD. TheMT1 gene has been shown to be downregulated in MCD patients, which may be an indication of the disease.

While further research is needed to fully understand the potential of MTND1P3 as a drug target and biomarker for MCD, its identification and characterization is an important step in the development of new treatments for this debilitating condition.

Protein Name: MT-ND1 Pseudogene 3

The "MTND1P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND1P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets